Share This Article
Metabolic fitness platform Ultrahuman announced on Tuesday that it has raised $17.5 Mn in Series B round. The round saw participation from well-known VC firms including Alpha Wave Incubation, Steadview Capital, Nexus Venture Partners, Blume Ventures and Utsav Somani’s iSeed fund. Many high-profile HNIs and angel investors also took part in the series B round. This included the likes of Tiger Global’s Scott Schleifer, Sandeep Singhal, Kunal Shah, Sujeet Kumar, Deepinder Goyal, Gunjan Patidar, Gaurav Munjal, Revant Bhate, Mohit Gupta, Vikram Dhingra and Roman Saini.
Following the Series B round, Ultrahuman’s external fundraising amount has now reached to approximately $25 Mn.
The company’s maiden round had taken place in December 2019, raising nearly $7Mn in a round led by Nexus Partners.
Ultrahuman was founded in 2019 by Mohit Kumar and Vatsal Singhal. The company was incorporated with the aim of improving people’s health and diet based on glucose biomarkers. The company claims that single biomarker like glucose can reveal great amount of information about the way body’s metabolic health responds to a particular diet or exercise. The company further claims that studying this response meticulously, which is unique for every individual, subsequently helps in improving their health.
“Biomarkers will change how the fitness and the healthcare industry works. By being able to continuously monitor their biomarkers like glucose, users can not only avoid chronic diseases but make lifestyle changes that help them improve their fitness levels for longevity and performance, ” said Ultrahuman Founder and CEO Mohit Kumar.
It must be noted that Kumar and Singhal’s previous startup Runnr had merged with Zomato. Ultrahuman is, therefore, Kumar and Singhal’s second startup in health and fitness space.
Ultrahuman competes with startups like Levels Health and SuperSapiens. Both startups are very well funded startups. Superspies had closed $13.5 Mn funding round in April this year, while Levels Health raised $12 Mn in November 2020.
